CRBP
Corbus Pharmaceuticals Holdings, Inc. · Healthcare
CEO Yuval Cohen sold $3.0M of Corbus Pharmaceuticals Holdings, Inc.
Sold$2,950,518
$46.57Price
63,358Shares
−45%Stake
What CRBP did after the filing
- The stock from Tue, Jun 18 close, $43.81
- +34.8%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Aug 1 close.
Traded Fri, Jun 14. Filed Tue, Jun 18, 1:58 PM ET, during the session. Returns use the Jun 18 close and the Aug 1 close. Not investment advice.